Philadelphia-based Trice Medical has raised $19.3m in a series C funding round to further develop its needle-based camera, which offers an alternative to traditional MRI scans. The mi-eye 2, a hand-held diagnostic imaging scope, features a wide-angle lens camera integrated within a disposable needle. “Many of the current methods for detecting and treating diseases are invasive or invasive-like — they involve inserting needles into your body through open wounds,” says CEO David DeAngelis. "The long-term goal is to eliminate the need for MRI exams and enable a quicker road to recovery,” said Trice Medical CEO Jeffrey O’Donnell.
Philadelphia-based Trice Medical has raised $19.3m in a series C funding round to further develop its needle-based camera, which offers an alternative to traditional MRI scans. The mi-eye 2, a hand-held diagnostic imaging scope, features a wide-angle lens camera integrated within a disposable needle. To use the device, doctors simply insert needles directly into an afflicted joint, where they can view the area with a 120-degree field on a connected Microsoft tablet. "The long-term goal is to eliminate the need for MRI exams and enable a quicker road to recovery,” said Trice Medical CEO Jeffrey O’Donnell.